Both in Pharmaceuticals
Heron Therapeutics vs Xilio Therapeutics
Over the past year HRTX returned −75.8% and XLO returned −34.1%; their daily moves had a correlation of -0.04.
HRTX −75.8% XLO −34.1%Growth of $1, one year, split-adjusted
| Metric | HRTX | XLO |
|---|---|---|
| Price | $0.2860 | $7.85 |
| Market cap | $54.3M | $51.6M |
| Today | +2.99% | −2.30% |
| 1 month | −17.7% | −12.9% |
| 6 months | −76.6% | −5.8% |
| Year to date | −78.0% | −12.5% |
| 1 year | −74.9% | −30.3% |
| Revenue growth (YoY) | +1.3% | +131.2% |
| Gross margin | 69.3% | 100.0% |
| Net margin | −14.6% | −34.1% |
| P/E (TTM) | — | — |
| Price / sales | 0.4× | 0.8× |
| Net cash | -$100.0M | $136.0M |
| Dividend yield | — | — |
| Volatility (60d) | 116.0% | 34.5% |
| Short % of float | 25.7% | 10.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).